课题基金 / 基金详情

A novel signal transducing adaptor molecule "STAM" involved in TCR-mediated signal transduction

A novel signal transducing adaptor molecule "STAM" involved in TCR-mediated signal transduction
一种参与TCR介导信号转导的新型信号转导接头分子“STAM”
批准号:
09670327
负责人:
TANAKA Nobuyuki
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

TANAKA Nobuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了STAM的功能意义,STAM先前被鉴定为与细胞因子受体的γ链相关的Jak 3酪氨酸激酶的底物。STAM与Jak 3和Jak 2直接相关,参与IL-2和GM-CSF介导的细胞生长和c-myc诱导的细胞内信号转导,并与TOR介导的信号转导必需分子SLP-76结合。野生型STAM的过表达诱导TCR介导的IL-2启动子活化的增强,表明STAM可能参与TCR介导的信号传导。另一方面,STAM被发现与一种名为AMSH的新分子相互作用。AMSH的功能意义尚未阐明,Grb 2家族的一个新成员Grf 40作为AMSH的相关分子被分离出来,Grf 40还显示与TCR信号传导所必需的SLP-76和LAT结合。Grf 40的SH 2缺失突变体在刺激TCR后抑制IL-2启动子活性的程度显著高于Grb 2的SH 2缺失突变体。这些结果表明Grf 40而不是Grb 2参与了TCR介导的信号传导。总之,本研究中克隆的STAM和Grf 40在TCR介导的信号传导中发挥了重要作用。
英文摘要
We investigated the functional significance of STAM, which was previously identified as a substrate for the Jak3 tyrosine kinase associated with the gammac chain of the cytokine receptors. STAM was shown to be directly associated with Jak3 and Jak2, and involved in intracellularsignal transduction for cell growth and c-myc induction mediated by at least IL-2 and GM-CSF.Furthermore, STAM was demonstrated to bind to SLP-76, an essential molecule for TOR-mediated signal transduction. Overexpression of the wild-type STAM induced enhancement of IL-2 promoter activation mediated by the TCR, suggesting a possible involvement of STAMin TCR-mediated signaling. On the other hand, STAM was found to interact with a novel molecule named AMSH.Although. the functional significance of AMSH has not yet been clarified, a new member of the Grb2 family, named Grf40, was isolated as an associated molecule with AMSH.Grf40 was also shown to bind to SLP-76 and LAT, which are essential for TCR signaling. The SH2 deletion mutant of Grf40 suppressed IL-2 promoter activity upon stimulation of the TCR significantly more than the SH2 deletion mutant of Grb2. These result suggest that Grf40 rather than Grb2 is involved in signaling mediated by TCR.In conclusion, STAM and Grf40, which were cloned in this research project, were shown to play important roles in the TCR-mediated signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Asao,H.: "Hrs is associated with STAM, an signal transducing adaptor molecule : Its suppressive effect on cytokine-induced cell growth" J.Biol.Chem.272. 32785-3279 (1997)
Asao,H.:“Hrs 与 STAM(一种信号转导接头分子)相关:其对细胞因子诱导的细胞生长的抑制作用”J.Biol.Chem.272。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka, N., Abe H., Yagita, H., Okumura, K., Nakamura, M.and Sugamura, K.: "Essential requirement of Itk, a T cell specific tyrosine kinase in CD2-mediated IL-2 promoter activation in human T cell line Jurkat" Eur.J.immunol.27. 834-841 (1997)
Tanaka, N.、Abe H.、Yagita, H.、Okumura, K.、Nakamura, M. 和 Sugamura, K.:“Itk(CD2 介导的 IL-2 启动子激活中的 T 细胞特异性酪氨酸激酶)的基本要求
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oda, K.: "Induction of IL-1 β converting enzyme-independent apoptosis by IL-2 human T cell lines." Int.Immunol.9. 1303-1310 (1997)
Oda, K.:“IL-2 人类 T 细胞系诱导 IL-1 β 转换酶依赖性细胞凋亡。”Int.Immunol.9 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
田中伸幸: "Induction of IL-1 b converting enzyme-independent apoptosis by IL-2 in human T cell lines." International Journal of Immunology. 9. 1303-1310 (1997)
Nobuyuki Tanaka:“IL-2 在人类 T 细胞系中诱导 IL-1 b 转化酶依赖性细胞凋亡”,《国际免疫学杂志》9. 1303-1310 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Estimating climatic controls of forest plants in East Asia and predicting their distribution changes in the past, present and future
    The role of high-resolution CT in the individual chemotherapheutic treatment for lung cancer
    • 批准号:
      25461826
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2013
    • 负责人:
      TANAKA Nobuyuki
    • 依托单位:
    Development of novel anti-inflammation therapy against deglycosylation of proinflammatory cytokine receptors.
    • 批准号:
      24659183
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      TANAKA Nobuyuki
    • 依托单位:
    The efficacy of renin-angiotensin system blockade for upper tract urothelial carcinoma
    • 批准号:
      24791671
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2012
    • 负责人:
      TANAKA Nobuyuki
    • 依托单位:
    国内基金
    海外基金
    高效Mage转座系统赋能KRAS G12D突变结直肠癌新型TCR-T疗法开发临床前研究
    双靶向CAR-TCR-T疗法克服小细胞肺癌肿瘤异质性的机制探索
    • 批准号:
      JCZRLH202601115
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    Piezo1驱动的人工合成TCR-T精准靶向肝癌的治疗研究
    • 批准号:
      2026JJ60274
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      肖潺潺
    • 依托单位:
    靶向PIK3CA突变的TCR-TCE NV制备及其在妊娠乳腺癌治疗中的研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李罗
    • 依托单位: